Results 131 to 140 of about 54,074 (258)

T‐cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first‐in‐human dose‐escalation trial for platinum‐resistant advanced ovarian cancer

open access: yesCancer, Volume 132, Issue 3, 1 February 2026.
Abstract Background Ovarian cancer remains a formidable therapeutic challenge due to late diagnosis, high recurrence rates, and limited treatment options. Mesothelin (MSLN) is highly expressed in ovarian cancer, making it a promising target for immunotherapy.
Yiyang Shan   +7 more
wiley   +1 more source

Supplementary Figure from Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer

open access: gold, 2023
Peter A. Fasching   +31 more
openalex   +2 more sources

Efficacy and safety of acupuncture therapy for leukopenia after chemotherapy or radiotherapy: A systematic review and meta-analysis

open access: hybrid
Yunpeng Deng   +9 more
openalex   +1 more source

A study on the mechanism of anemia and leukopenia in liver cirrhosis.

open access: bronze, 1988
Ichiro Ohki   +3 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy